---
document_datetime: 2024-12-05 12:44:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/theralugand-epar-all-authorised-presentations_en.pdf
document_name: theralugand-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3306917
conversion_datetime: 2025-12-25 05:18:46.590184
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Immediate Packaging Content (concentration) Pack size

EU/1/24/1852/001 Theralugand 40 GBq/ml Radiopharmaceutical precursor, solution vial (glass) 0.1 - 3 ml 1 vial EU/1/24/1852/002 Theralugand 40 GBq/ml Radiopharmaceutical precursor, solution vial (glass) 0.3 - 5 ml 1 vial